Review
Copyright ©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 741-754
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.741
Table 2 Methods of estimating glomerular filtration rate and the novel biomarkers for diagnosis of acute kidney injury in cirrhosis
Ref.
Biomarker
Year Published-Patient population
Advantage(s)
Limitation(s)
Fagundes et al[102]NGAL and/or IL-182012-CirrhosisBest supporting data; can differentiate HRS-AKI and ATN; predicts AKI progression; predicts mortality; NGAL has good performance in patients with ACLFIncreased in inflammation and infections (UTI); lack of standard cut-offs
Verna et al[103]2012-Cirrhosis
Tsai et al[104]2013-Cirrhosis
Gungor et al[105]2014-Cirrhosis
Belcher et al[55]2014-Cirrhosis
Barreto et al[106]2014-Cirrhosis
Qasem et al[56]2014-Cirrhosis
Treeprasertsuk et al[107]2015-Cirrhosis
Ariza et al[57]2015-Cirrhosis
Markwardt et al[59]Cystatin C2017-CirrhosisPredicts AKI progression; predicts short-term mortality; Used in combination with MELD score (MELD-cystatin score)Increases in CKD
Maiwall et al[60]2017-Cirrhosis
Jaques et al[108]2019-Cirrhosis
Belcher et al[55]KIM-12014-CirrhosisPredicts AKI progression; Predicts short-term mortalityLow sensitivity and specificity for differentiating causes of AKI
Ariza et al[57]2015-Cirrhosis
Belcher et al[55]L-FABP2014-Cirhrosis Predicts AKI progression; predicts short-term mortality Increased in CKD; poor performance in differentiating causes of AKI
Jiang et al[109]2018-Cirrhosis
Belcher et al[55]Albumin 2014-CirrhosisCan differentiate HRS-AKI and ATN; good performance in ACLF; predicts short-term mortality; readily availableDecreased level in advanced cirrhosis